Intravenous immunoglobulin therapy among pediatric patients: labeled and off-labeled indications
Braz. J. Pharm. Sci. (Online)
;
54(1): e00008, 2018. tab
Article
Dans Anglais
| LILACS
| ID: biblio-889445
ABSTRACT
ABSTRACT This study was designed to evaluate utilization patterns and clinical outcome of intravenous immunoglobulin (IVIG) therapy among pediatric patients in a tertiary hospital. Demographic data, IVIG prescribed, and clinical outcome were retrospectively reviewed from the pharmacy dispensing data and patient medical records between 2007 and 2014. One hundred and fifteen instances of IVIG administration to 108 pediatric patients were recorded. A total of 61 cases (53%) and 54 cases (47%) of the IVIG administered were for labeled and off-labeled indications, respectively. Age, weight, specialty, total IVIG usage, length of hospital stays, and mortality rate were found to be significantly associated with the indication being labeled or off-labeled (p<0.05). However, there was no significant difference in terms of adverse reactions between labeled and off-labeled indications (p>0.05). Guidelines should be developed and implemented for rational and evidence-based use of IVIG to avoid unnecessary wastage.
Texte intégral:
Disponible
Indice:
LILAS (Amériques)
Sujet Principal:
Thérapeutique
/
Santé de l'enfant
/
Immunoglobulines par voie veineuse
Type d'étude:
Guide de pratique
Limites du sujet:
Enfant
/
Enfant d'âge préscolaire
/
Humains
/
Bébé
/
Nouveau-né
langue:
Anglais
Texte intégral:
Braz. J. Pharm. Sci. (Online)
Thème du journal:
Farmacologia
/
Teraputica
/
Toxicologia
Année:
2018
Type:
Article
Pays d'affiliation:
Malaisie
Institution/Pays d'affiliation:
Universiti Kebangsaan Malaysia/MY
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS